UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 211

Sortiert nach

Mechanisms of RANKL delivery to the osteoclast precursor cell surface

Journal of bone and mineral metabolism, 2021-01, Vol.39 (1), p.27-33

2021

Volltextzugriff (PDF)

Can molecular dynamics facilitate the design of protein-protein-interaction inhibitors?

Nature reviews. Rheumatology, 2023-01, Vol.19 (1), p.8-9

2023

Volltextzugriff (PDF)

RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a pharmacological target

Pharmacology & therapeutics (Oxford), 2021-02, Vol.218, p.107682-107682, Article 107682

2021

Volltextzugriff (PDF)

Applications of model simulation in pharmacological fields and the problems of theoretical reliability

Drug metabolism and pharmacokinetics, 2024-06, Vol.56, p.100996, Article 100996

2024

Volltextzugriff (PDF)

Utility of constraints reflecting system stability on analyses for biological models

PLoS computational biology, 2022-09, Vol.18 (9), p.e1010441-e1010441

2022

Volltextzugriff (PDF)

RANKL subcellular trafficking and regulatory mechanisms in osteocytes

Journal of bone and mineral research, 2013-09, Vol.28 (9), p.1936-1949

2013

Volltextzugriff (PDF)

Off-target serine/threonine kinase 10 inhibition by erlotinib enhances lymphocytic activity leading to severe skin disorders

Molecular pharmacology, 2011-09, Vol.80 (3), p.466-475

2011

Volltextzugriff (PDF)

Regulatory Mechanisms of RANKL Presentation to Osteoclast Precursors

Current osteoporosis reports, 2014-03, Vol.12 (1), p.115-120

2014

Volltextzugriff (PDF)

The induction of RANKL molecule clustering could stimulate early osteoblast differentiation

Biochemical and biophysical research communications, 2019-02, Vol.509 (2), p.435-440

2019

Volltextzugriff (PDF)

Study on Horizon Scanning with a Focus on the Development of AI-Based Medical Products: Citation Network Analysis

Therapeutic innovation & regulatory science, 2022-03, Vol.56 (2), p.263-275

2022

Volltextzugriff (PDF)

Establishment of optimized in vitro assay methods for evaluating osteocyte functions

Journal of bone and mineral metabolism, 2015-01, Vol.33 (1), p.73-84

2015

Volltextzugriff (PDF)

Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling

BioEssays, 2016-08, Vol.38 (8), p.717-725

2016

Volltextzugriff (PDF)

Study on Horizon Scanning by Citation Network Analysis and Text Mining: A Focus on Drug Development Related to T Cell Immune Response

Therapeutic innovation & regulatory science, 2022-03, Vol.56 (2), p.230-243

2022

Volltextzugriff (PDF)

The potential of RANKL reverse signaling as a novel pharmacological target

Folia Pharmacologica Japonica, 2023/05/01, Vol.158(3), pp.253-257

Honma, Masashi

2023

Volltextzugriff (PDF)

Metabolic Profiling to Identify Potential Serum Biomarkers for Gastric Ulceration Induced by Nonsteroid Anti-Inflammatory Drugs

Journal of proteome research, 2013-03, Vol.12 (3), p.1399-1407

2013

Volltextzugriff (PDF)

Integrative and theoretical research on the architecture of a biological system and its disorder

The journal of physiological sciences, 2019-05, Vol.69 (3), p.433-451

2019

Volltextzugriff (PDF)

Quantitative prediction of in vivo profiles of CYP3A4 induction in humans from in vitro results with a reporter gene assay

Drug metabolism and disposition, 2009-06, Vol.37 (6), p.1234

2009

Volltextzugriff (PDF)

Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis

Journal of bone and mineral research, 2010-09, Vol.25 (9), p.1907-1921

2010

Volltextzugriff (PDF)

Rab27a and Rab27b are involved in stimulation‐dependent RANKL release from secretory lysosomes in osteoblastic cells

Journal of bone and mineral research, 2011-04, Vol.26 (4), p.689-703

2011

Volltextzugriff (PDF)

Vps33a Mediates RANKL Storage in Secretory Lysosomes in Osteoblastic Cells

Journal of bone and mineral research, 2009-10, Vol.24 (10), p.1741-1752

2009

Volltextzugriff (PDF)

Metabolomic analysis of the effects of omeprazole and famotidine on aspirin-induced gastric injury

Metabolomics, 2014-10, Vol.10 (5), p.995-1004

2014

Volltextzugriff (PDF)

Coupling of bone resorption and formation by RANKL reverse signalling

Nature (London), 2018-09, Vol.561 (7722), p.195-200

2018

Volltextzugriff (PDF)

Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide

Drug metabolism and disposition, 2010-10, Vol.38 (10), p.1828

2010

Volltextzugriff (PDF)

Relationship between the Expression of Advanced Glycation End-Products (AGE) and the Receptor for AGE (RAGE) mRNA in Diabetic Nephropathy

Internal Medicine, 2006, Vol.45(7), pp.435-441

2006

Volltextzugriff (PDF)

Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-deficient (Gunn) rats

Drug metabolism and disposition, 2007-09, Vol.35 (9), p.1455

2007

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(196)

Publikationsform

Sprache

Englisch
(183)
Japanisch
(102)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of RANKL delivery to the osteoclast precursor cell surface

Can molecular dynamics facilitate the design of protein-protein-interaction inhibitors?

RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a pharmacological target

Applications of model simulation in pharmacological fields and the problems of theoretical reliability

Utility of constraints reflecting system stability on analyses for biological models

RANKL subcellular trafficking and regulatory mechanisms in osteocytes

Off-target serine/threonine kinase 10 inhibition by erlotinib enhances lymphocytic activity leading to severe skin disorders

Regulatory Mechanisms of RANKL Presentation to Osteoclast Precursors

The induction of RANKL molecule clustering could stimulate early osteoblast differentiation

Study on Horizon Scanning with a Focus on the Development of AI-Based Medical Products: Citation Network Analysis

Establishment of optimized in vitro assay methods for evaluating osteocyte functions

Peptide drugs accelerate BMP-2-induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling

Study on Horizon Scanning by Citation Network Analysis and Text Mining: A Focus on Drug Development Related to T Cell Immune Response

The potential of RANKL reverse signaling as a novel pharmacological target

Metabolic Profiling to Identify Potential Serum Biomarkers for Gastric Ulceration Induced by Nonsteroid Anti-Inflammatory Drugs

Integrative and theoretical research on the architecture of a biological system and its disorder

Quantitative prediction of in vivo profiles of CYP3A4 induction in humans from in vitro results with a reporter gene assay

Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis

Rab27a and Rab27b are involved in stimulation‐dependent RANKL release from secretory lysosomes in osteoblastic cells

Vps33a Mediates RANKL Storage in Secretory Lysosomes in Osteoblastic Cells

Metabolomic analysis of the effects of omeprazole and famotidine on aspirin-induced gastric injury

Coupling of bone resorption and formation by RANKL reverse signalling

Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide

Relationship between the Expression of Advanced Glycation End-Products (AGE) and the Receptor for AGE (RAGE) mRNA in Diabetic Nephropathy

Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-deficient (Gunn) rats

Suchergebnisse filtern